Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses

NCT ID: NCT00613184

Last Updated: 2008-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Study Completion Date

2008-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Collection of nasal secretions from infants and toddlers for viral testing is usually done using the nasal washing technique described by Hall in 1975. This is cumbersome. Previous attempts to use swabs have been unsuccessful because the swabs didn't work well. A newly designed swab may work better and in this study we compare the new swab with the old style nasal washing.

.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Collection of nasal secretions from infants and toddlers for viral testing is typically performed using the nasal saline aspirate technique described by Hall in 1975.

Nylon flocked swabs (NFS) and universal transport medium for room temperature (UTM-RT) (Copan Medical, Murrieta, CA) storage media have been found to be an effective collection and transport method for bacteria causing sexually transmitted infections.

We adapted these swabs and storage medium to collect respiratory viruses from children less than18 months old and compared detection rates using NFS and traditional nasal aspirates. We will determine the relative roles of the UTM-RT and NFS release and therefore measured viral detection rates of common respiratory pathogens in traditional saline aspirates stored in UTM-RT.

Our primary hypothesis is that nasal secretions collection using NFS stored in UTM-RT will lead to a higher detection rate of the respiratory viruses we arestudying; namely RSV, Influenza and human metapneumovirus from than collection of unpreserved saline nasal aspirates in children less than 18 months of age.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Syncytial Virus Human Metapneumovirus Influenza Bronchiolitis Pediatric

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Nylon Flocked swab Left Nasal Wash right

Group Type EXPERIMENTAL

Nylon Flocked swab (Nasal secretion sampling)

Intervention Type DEVICE

Nasal Aspirate Nylon Flocked swab

Nylon Flocked swab (Nasal secretion sampling)

Intervention Type DEVICE

Nylon flocked swab Nasal Wash

2

Nylon Flocked swab R Nasal Wash L

Group Type EXPERIMENTAL

Nylon Flocked swab (Nasal secretion sampling)

Intervention Type DEVICE

Nasal Aspirate Nylon Flocked swab

3

Nasal Wash Left Nylon Flocked swab Right

Group Type EXPERIMENTAL

Nylon Flocked swab (Nasal secretion sampling)

Intervention Type DEVICE

Nasal Aspirate Nylon Flocked swab

4

Nasal Wash R Nylon flocked swab L

Group Type EXPERIMENTAL

Nylon Flocked swab (Nasal secretion sampling)

Intervention Type DEVICE

Nasal Aspirate Nylon Flocked swab

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nylon Flocked swab (Nasal secretion sampling)

Nasal Aspirate Nylon Flocked swab

Intervention Type DEVICE

Nylon Flocked swab (Nasal secretion sampling)

Nylon flocked swab Nasal Wash

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Treating clinican ordered RSV antigen testing

Exclusion Criteria

* Refusal of consent
* Age \> 18 months
Maximum Eligible Age

18 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical Diagnostic Laboratories, LLC

INDUSTRY

Sponsor Role collaborator

Copan Innovation Murrietta, CA

UNKNOWN

Sponsor Role collaborator

Kern Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Department of Emergency Medicine, Kern Medical Center

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul Walsh, MD

Role: PRINCIPAL_INVESTIGATOR

Kern Medical Center & David Geffen School of Medicine UCLA

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

kmc06037

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Nasal Swab Trial
NCT04649424 COMPLETED NA
Inpatient COVID-19 Lollipop Study
NCT05801341 TERMINATED NA